139 related articles for article (PubMed ID: 22228346)
21. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
22. Papillary serous cystadenofibroma of the ovary--is it really so rare?
Fatum M; Rojansky N; Shushan A
Int J Gynaecol Obstet; 2001 Oct; 75(1):85-6. PubMed ID: 11597627
[No Abstract] [Full Text] [Related]
23. (131)I SPECT/CT demonstrated ovarian endometrioma.
Chuang TL; Hsu CS; Wang YF
Clin Nucl Med; 2014 Feb; 39(2):193-5. PubMed ID: 24300362
[TBL] [Abstract][Full Text] [Related]
24. Metastatic papillary carcinoma of the thyroid in a patient previously treated for Graves' disease.
Yunusa GH; Kotze T; Brink A
Ann Afr Med; 2014; 13(2):91-4. PubMed ID: 24705115
[TBL] [Abstract][Full Text] [Related]
25. Unusual ¹³¹I uptake in a benign mucinous cystadenoma of the ovary in a patient with papillary thyroid cancer.
Qiu ZL; Xu YH; Song HJ; Luo QY
Clin Nucl Med; 2010 Dec; 35(12):965-6. PubMed ID: 21206234
[No Abstract] [Full Text] [Related]
26. Serous adenofibroma and cystadenofibroma of the ovary: report of five cases with malignant changes in one.
ROTHMAN D; BLUMENTHAL HT
Obstet Gynecol; 1959 Sep; 14():389-93. PubMed ID: 14439461
[No Abstract] [Full Text] [Related]
27. False-positive iodine-131 whole-body scan findings in patients with differentiated thyroid carcinoma: report of 11 cases and review of the literature.
Buton L; Morel O; Gault P; Illouz F; Rodien P; Rohmer V
Ann Endocrinol (Paris); 2013 Jul; 74(3):221-30. PubMed ID: 23796008
[TBL] [Abstract][Full Text] [Related]
28. Adrenal metastasis secondary to papillary thyroid carcinoma.
Koutkia P; Safer JD
Thyroid; 2001 Nov; 11(11):1077-9. PubMed ID: 11762719
[TBL] [Abstract][Full Text] [Related]
29. Pitfalls of I-131 whole body scan interpretation: bronchogenic cyst and mucinous cystadenoma.
Agriantonis DJ; Hall L; Wilson MA
Clin Nucl Med; 2008 May; 33(5):325-7. PubMed ID: 18431144
[TBL] [Abstract][Full Text] [Related]
30. Frontal sinus mucocele mimicking a metastasis of papillary thyroid carcinoma.
Matheja P; Lerch H; Schmid KW; Kuwert T; Schober O
J Nucl Med; 1997 Jul; 38(7):1022-4. PubMed ID: 9225783
[TBL] [Abstract][Full Text] [Related]
31. Cystic ovarian metastasis from papillary thyroid carcinoma: a case report.
Logani S; Baloch ZW; Snyder PJ; Weinstein R; LiVolsi VA
Thyroid; 2001 Nov; 11(11):1073-5. PubMed ID: 11762718
[TBL] [Abstract][Full Text] [Related]
32. Computed tomography of benign ovarian masses.
Sawyer RW; Vick CW; Walsh JW; McClure PH
J Comput Assist Tomogr; 1985; 9(4):784-9. PubMed ID: 4019837
[TBL] [Abstract][Full Text] [Related]
33. Radioiodine therapy for thyroid cancer depicted uterine leiomyoma.
Hirata K; Shiga T; Kubota KC; Okamoto S; Kamibayashi T; Tamaki N
Clin Nucl Med; 2009 Mar; 34(3):180-1. PubMed ID: 19352287
[TBL] [Abstract][Full Text] [Related]
34. False-Positive 131 I Uptake After Posttraumatic Scab in a Patient With Papillary Thyroid Carcinoma.
Yang J; Zhou P; Su X
Clin Nucl Med; 2023 Dec; 48(12):e598-e599. PubMed ID: 37801578
[TBL] [Abstract][Full Text] [Related]
35. A case of ovarian serous cystadenofibroma with scattered lesions in pelvic cavity, like malignant disseminations.
Fujita K; Ogawa C; Sako T; Utsumi F; Inada KI; Shibata K
J Obstet Gynaecol Res; 2021 Dec; 47(12):4496-4501. PubMed ID: 34490687
[TBL] [Abstract][Full Text] [Related]
36. Abnormal ¹³¹I uptake in a benign serous ovarian cystadenoma mimicking bladder physiological uptake.
Song HJ; Xue YL; Xu YH; Qiu ZL; Luo QY
Clin Nucl Med; 2012 Mar; 37(3):e59-60. PubMed ID: 22310273
[No Abstract] [Full Text] [Related]
37. [False positive scintigraphic images in the surveillance of differentiated thyroid cancers].
Rudoni S; Toubeau M; Mansuy S; Vaillant G; Verges B; Brun JM; Brunotte F
Ann Endocrinol (Paris); 1997; 58(5):399-407. PubMed ID: 9685998
[TBL] [Abstract][Full Text] [Related]
38. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
Dennis K; Hay JH; Wilson DC
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
[TBL] [Abstract][Full Text] [Related]
39. False-positive findings on (131)I whole-body scans because of posttraumatic superficial scabs.
Regalbuto C; Buscema M; Arena S; Vigneri R; Squatrito S; Pezzino V
J Nucl Med; 2002 Feb; 43(2):207-9. PubMed ID: 11850486
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.
Valli N; Catargi B; Ronci N; Leccia F; Guyot M; Roger P; Ducassou D; Tabarin A
Thyroid; 1999 Jun; 9(6):583-9. PubMed ID: 10411121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
